Ubrelvy

Question 1

Is it safe to take UBRELVY during pregnancy?

Accepted Answer

There are no adequate data on the developmental risk associated with the use of UBRELVY in pregnant women. Patients should be encouraged to enroll in the pregnancy exposure registry that monitors outcomes in women who become pregnant while taking UBRELVY by calling 1-833-277-0206 or visiting http://empresspregnancyregistry.com.

Question 2

What is the risk of birth defects or miscarriage when taking UBRELVY during pregnancy?

Accepted Answer

In the U.S. general population, the estimated background risk of major birth defects and miscarriages in clinically recognized pregnancies is 2-4% and 15-20%, respectively. The estimated rate of major birth defects (2.2% -2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine. However, no adequate data on the developmental risk associated with the use of UBRELVY in pregnant women is available.

Question 3

What are the clinical considerations when taking UBRELVY during pregnancy?

Accepted Answer

Published data have suggested that women with migraine may be at increased risk of preeclampsia and gestational hypertension during pregnancy.

Question 4

What does animal data suggest about the use of UBRELVY during pregnancy?

Accepted Answer

In animal studies, adverse effects on embryofetal development were observed following administration of ubrogepant during pregnancy or during pregnancy and lactation at doses greater than those used clinically and which were associated with maternal toxicity. No adverse effects on embryofetal development were observed when ubrogepant was administered to pregnant rats during the period of organogenesis. However, no adequate data on the developmental risk associated with the use of UBRELVY in pregnant women is available.

Question 5

What is the risk of taking UBRELVY while breastfeeding?

Accepted Answer

There are no data on the presence of ubrogepant in human milk, the effects of ubrogepant on the breastfed infant, or the effects of ubrogepant on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for UBRELVY and any potential adverse effects on the breastfed infant from UBRELVY or from the underlying maternal condition.

Question 6

Is it safe to use UBRELVY in pediatric patients?

Accepted Answer

Safety and effectiveness in pediatric patients have not been established.

Question 7

Are there any pharmacokinetic differences between elderly and younger patients when taking UBRELVY?

Accepted Answer

Pharmacokinetic studies have shown no clinically significant differences between elderly and younger patients when taking UBRELVY.

Question 8

Was the use of UBRELVY studied in elderly patients?

Accepted Answer

Clinical studies of UBRELVY did not include enough elderly patients to determine if they respond differently from younger patients. Dose selection for elderly patients should be cautious and typically start at the low end of the dosing range.

Question 9

How does hepatic impairment affect the exposure to UBRELVY?

Accepted Answer

In patients with mild, moderate, or severe hepatic impairment, exposure to UBRELVY was increased by 7%, 50%, and 115%, respectively. No dose adjustment is necessary for mild or moderate hepatic impairment. However, for patients with severe hepatic impairment, dose adjustment is recommended.

Question 10

How does renal impairment affect the use of UBRELVY?

Accepted Answer

Renal impairment has a minor effect on the clearance of UBRELVY. No dose adjustment is needed for patients with mild or moderate renal impairment. For those with severe renal impairment (CLcr 15-29 mL/min), dose adjustment is necessary. Patients with end-stage renal disease (CLcr <15 mL/min) should avoid the use of UBRELVY.

Dosage & Administration

Get Your Patient on Ubrelvy

Ubrelvy Prescribing Information

Request Ubrelvy Samples

Is my patient eligible for Ubrelvy samples?

How do I find out who my Ubrelvy rep is?

Ubrelvy Prior Authorization Resources

Most recent state uniform prior authorization forms

Ubrelvy Financial Assistance Options

Copay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Ubrelvy PubMed™ News

Ubrelvy Patient Education

Patient toolkit

Ubrelvy FAQs